| Topic |
Author |
Posted On |
| Engineered Phage Lysins |
cataliesw |
on 22/2/25 |
| The modular structure of lysin is composed of at least two domains, including an N-terminal catalytic domain (CD) for enzymatic hydrolysis and a C-terminal cell wall binding domain (CBD) for substrate recognition. Learn more:Engineered Phage Lysins |
| Cell Culture and Organ-On-A-Chip Model Development Services |
cataliesw |
on 22/2/25 |
| MFMM1-Flow is an easy-to-use device for long-term 2D/3D cell culture and mechanical shear stress studies by means of microfluidics. Learn more: Cell Culture and Organ-On-A-Chip Model Development Services |
| Zebrafish Antibody |
cataliesw |
on 22/2/25 |
| Danio rerio (zebrafish) is a small fish that shines in biomedical research. Zebrafish lay hundreds of eggs that develop externally, allowing scientists to manipulate genes and monitor early phenotypes in complex organisms. Learn more: Zebrafish Antibody |
| Development of FGFR-based Bispecific ADCs |
cataliesw |
on 24/1/25 |
| An appealing and innovative treatment is the bispecific antibody-drug combination (ADC), which delivers targeted cytotoxic drugs with increased efficacy and less non-specific cytotoxic effects while directly targeting tumor-associated cell-surface antigens. Learn more: Development of FGFR-based Bispecific ADCs |
| antibody-drug conjugates |
cataliesw |
on 20/1/25 |
| Antibody-drug conjugates (ADCs) inherit such superiorities and more remarkably, expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature. |
